Ralexar Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Ralexar Therapeutics General Information

Description

Developer of topical and systemic therapies designed to treat various dermatological conditions. The company's therapies are based on liver X receptor modulators for the treatment of different cutaneous inflammatory disorders, including atopic dermatitis, enabling patients to begin treatment early and resulting in a higher likelihood of successful treatment.

Contact Information

Website
www.ralexar.com
Formerly Known As
Alexar Therapeutics, Alexar
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 640 Lee Road
  • Suite 118
  • Wayne, PA 19087
  • United States
+1 (484)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 640 Lee Road
  • Suite 118
  • Wayne, PA 19087
  • United States
+1 (484)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ralexar Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Apr-2026 Completed Generating Revenue
4. Later Stage VC 25-Mar-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 06-Jun-2017 Completed Startup
2. Grant 23-Jan-2015 $21.5M Completed Startup
1. Early Stage VC (Series A) 02-Jan-2014 $21.5M $21.5M Completed Startup
To view Ralexar Therapeutics’s complete valuation and funding history, request access »

Ralexar Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A2
Series A1 8,600,000 $0.000100 7% $1 $1 1x $1 21.93%
To view Ralexar Therapeutics’s complete cap table history, request access »

Ralexar Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of topical and systemic therapies designed to treat various dermatological conditions. The company's therapies
Drug Discovery
Wayne, PA

Lexington, MA
 

Sunnyvale, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ralexar Therapeutics Competitors (86)

One of Ralexar Therapeutics’s 86 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
BioCardia Formerly VC-backed Sunnyvale, CA
Enterome Venture Capital-Backed Paris, France
Mighty Therapeutics Private Equity-Backed Needham, MA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
You’re viewing 5 of 86 competitors. Get the full list »

Ralexar Therapeutics Patents

Ralexar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014315206-A1 Liver x receptor (lxr) modulators Inactive 04-Sep-2013
EP-3041834-A1 Liver x receptor (lxr) modulators Inactive 04-Sep-2013
EP-3041834-A4 Liver x receptor (lxr) modulators Inactive 04-Sep-2013
US-10246419-B2 Liver x receptor (lxr) modulators Active 04-Sep-2013
US-20160214943-A1 Liver x receptor (lxr) modulators Active 04-Sep-2013 C07D231/12
To view Ralexar Therapeutics’s complete patent history, request access »

Ralexar Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
NeXeption Corporation Minority
To view Ralexar Therapeutics’s complete investors history, request access »

Ralexar Therapeutics FAQs

  • When was Ralexar Therapeutics founded?

    Ralexar Therapeutics was founded in 2014.

  • Where is Ralexar Therapeutics headquartered?

    Ralexar Therapeutics is headquartered in Wayne, PA.

  • What industry is Ralexar Therapeutics in?

    Ralexar Therapeutics’s primary industry is Drug Discovery.

  • Is Ralexar Therapeutics a private or public company?

    Ralexar Therapeutics is a Private company.

  • What is Ralexar Therapeutics’s current revenue?

    The current revenue for Ralexar Therapeutics is .

  • How much funding has Ralexar Therapeutics raised over time?

    Ralexar Therapeutics has raised $29.9M.

  • Who are Ralexar Therapeutics’s investors?

    NeXeption has invested in Ralexar Therapeutics.

  • Who are Ralexar Therapeutics’s competitors?

    Voyager Therapeutics, BioCardia, Enterome, Mighty Therapeutics, and Vertex Pharmaceuticals are some of the 86 competitors of Ralexar Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process